Cargando…

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma

INTRODUCTION: To date, an increasing number of studies have revealed that GP73 may have prognostic value in liver cancer. However, most of the studies evaluated serum GP73, and the results regarding the prognostic value of tGP73 in liver cancer are still controversial. Therefore, in this meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wei-Ming, Li, Guo-Wei, Lou, Ming-Geng, Wu, Zheng-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656938/
https://www.ncbi.nlm.nih.gov/pubmed/37978447
http://dx.doi.org/10.1186/s12876-023-03050-5
_version_ 1785148102816038912
author Yu, Wei-Ming
Li, Guo-Wei
Lou, Ming-Geng
Wu, Zheng-Yu
author_facet Yu, Wei-Ming
Li, Guo-Wei
Lou, Ming-Geng
Wu, Zheng-Yu
author_sort Yu, Wei-Ming
collection PubMed
description INTRODUCTION: To date, an increasing number of studies have revealed that GP73 may have prognostic value in liver cancer. However, most of the studies evaluated serum GP73, and the results regarding the prognostic value of tGP73 in liver cancer are still controversial. Therefore, in this meta-analysis, we aimed to determine whether tGP73 has any prognostic value in patients with HCC. MATERIALS AND METHODS: Relevant publications were searched for in PubMed, EMBASE, OVID, the Cochrane Library, and the Web of Science databases up to March 2023. The hazard ratio (HR) or odds ratio (OR) with corresponding 95% confidence intervals (95% CIs) of eligible studies were assessed by fixed-effects or random-effects models. In addition, subgroup analyses were conducted to investigate the possible causes of heterogeneity, and publication bias analysis was also performed to assess the reliability of the meta-analysis results. RESULTS: A total of 10 studies were included. These studies included 1569 HCC patients, and a meta-analysis was performed. The results of our meta-analysis showed that higher GP73 expression levels were significantly associated with poorer OS (HR = 1.87, 95% CI: 1.41–2.48, P < 0.0001, I(2) = 58%). However, there was no significant correlation between high GP73 expression and disease-free survival (DFS) (HR: 1.43, 95% CI: 0.93–2.33, P = 0.100). In addition, abnormal GP73 expression was also related to higher tumour tissue differentiation grade (OR = 3.03, 95% CI = 2.01–4.57, P < 0.0001, I(2) = 89%), later tumour stage (OR = 5.89, 95% CI = 2.31–14.99, P < 0.0001, I(2) = 0%), vascular invasion (OR = 1.72, 95% CI = 1.12–2.64, P = 0.010, I(2) = 0%), multiple tumours (OR = 2.44, 95% CI = 1.37–3.68, P = 0.001, I(2) = 44%) and early postoperative tumour recurrence (OR = 1.92, 95% CI = 1.10–3.28, P = 0.020, I(2) = 62%). CONCLUSIONS: The meta-analysis showed that the overexpression of GP73 may be related to a poor prognosis of HCC, and it may also have a predictive effect on the invasion and metastasis of HCC.
format Online
Article
Text
id pubmed-10656938
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106569382023-11-17 A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma Yu, Wei-Ming Li, Guo-Wei Lou, Ming-Geng Wu, Zheng-Yu BMC Gastroenterol Research INTRODUCTION: To date, an increasing number of studies have revealed that GP73 may have prognostic value in liver cancer. However, most of the studies evaluated serum GP73, and the results regarding the prognostic value of tGP73 in liver cancer are still controversial. Therefore, in this meta-analysis, we aimed to determine whether tGP73 has any prognostic value in patients with HCC. MATERIALS AND METHODS: Relevant publications were searched for in PubMed, EMBASE, OVID, the Cochrane Library, and the Web of Science databases up to March 2023. The hazard ratio (HR) or odds ratio (OR) with corresponding 95% confidence intervals (95% CIs) of eligible studies were assessed by fixed-effects or random-effects models. In addition, subgroup analyses were conducted to investigate the possible causes of heterogeneity, and publication bias analysis was also performed to assess the reliability of the meta-analysis results. RESULTS: A total of 10 studies were included. These studies included 1569 HCC patients, and a meta-analysis was performed. The results of our meta-analysis showed that higher GP73 expression levels were significantly associated with poorer OS (HR = 1.87, 95% CI: 1.41–2.48, P < 0.0001, I(2) = 58%). However, there was no significant correlation between high GP73 expression and disease-free survival (DFS) (HR: 1.43, 95% CI: 0.93–2.33, P = 0.100). In addition, abnormal GP73 expression was also related to higher tumour tissue differentiation grade (OR = 3.03, 95% CI = 2.01–4.57, P < 0.0001, I(2) = 89%), later tumour stage (OR = 5.89, 95% CI = 2.31–14.99, P < 0.0001, I(2) = 0%), vascular invasion (OR = 1.72, 95% CI = 1.12–2.64, P = 0.010, I(2) = 0%), multiple tumours (OR = 2.44, 95% CI = 1.37–3.68, P = 0.001, I(2) = 44%) and early postoperative tumour recurrence (OR = 1.92, 95% CI = 1.10–3.28, P = 0.020, I(2) = 62%). CONCLUSIONS: The meta-analysis showed that the overexpression of GP73 may be related to a poor prognosis of HCC, and it may also have a predictive effect on the invasion and metastasis of HCC. BioMed Central 2023-11-17 /pmc/articles/PMC10656938/ /pubmed/37978447 http://dx.doi.org/10.1186/s12876-023-03050-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yu, Wei-Ming
Li, Guo-Wei
Lou, Ming-Geng
Wu, Zheng-Yu
A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title_full A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title_fullStr A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title_full_unstemmed A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title_short A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
title_sort meta-analysis of the prognostic impact of tissue golgi protein 73 (tgp73) in hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656938/
https://www.ncbi.nlm.nih.gov/pubmed/37978447
http://dx.doi.org/10.1186/s12876-023-03050-5
work_keys_str_mv AT yuweiming ametaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT liguowei ametaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT louminggeng ametaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT wuzhengyu ametaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT yuweiming metaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT liguowei metaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT louminggeng metaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma
AT wuzhengyu metaanalysisoftheprognosticimpactoftissuegolgiprotein73tgp73inhepatocellularcarcinoma